Pharmarise Holdings Corp. said its normalized net income for the fiscal first quarter ended Aug. 31 came to ¥6.13 per share, a decline of 76.4% from ¥26.00 per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥55.1 million, a decrease of 71.7% from ¥195.0 million in the year-earlier period.
The normalized profit margin fell to 0.6% from 2.1% in the year-earlier period.
Total revenue rose on an annual basis to ¥9.44 billion from ¥9.14 billion, and total operating expenses grew 6.1% year over year to ¥9.29 billion from ¥8.76 billion.
Reported net income came to a loss of ¥11.0 million, or a loss of ¥1.22 per share, compared to income of ¥140.0 million, or ¥18.67 per share, in the year-earlier period.
As of Oct. 15, US$1 was equivalent to ¥106.21.
